HEADER TRANSFERASE 21-MAR-17 5NHF TITLE HUMAN ERK2 WITH AN ERK1/2 INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: MITOGEN-ACTIVATED PROTEIN KINASE 1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: MAPK 1,ERT1,EXTRACELLULAR SIGNAL-REGULATED KINASE 2,ERK-2, COMPND 5 MAP KINASE ISOFORM P42,P42-MAPK,MITOGEN-ACTIVATED PROTEIN KINASE 2, COMPND 6 MAPK 2; COMPND 7 EC: 2.7.11.24; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MAPK1, ERK2, PRKM1, PRKM2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS ERK2, KINASE, INHIBITOR, ONCOLOGY, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR J.E.DEBRECZENI,R.A.WARD,P.BETHEL,C.COOK,E.DAVIES,K.ECKERSLEY, AUTHOR 2 G.FAIRLEY,L.FERON,V.FLEMINGTON,M.A.GRAHAM,R.GREENWOOD,P.HOPCROFT, AUTHOR 3 T.D.HOWARD,J.HUDSON,M.JAMES,C.D.JONES,C.R.JONES,S.LAMONT,R.LEWIS, AUTHOR 4 N.LINDSAY,K.ROBERTS,I.SIMPSON,S.STGALLAY,S.SWALLOW,M.TONGE REVDAT 2 10-MAY-17 5NHF 1 JRNL REVDAT 1 19-APR-17 5NHF 0 JRNL AUTH R.A.WARD,P.BETHEL,C.COOK,E.DAVIES,J.E.DEBRECZENI,G.FAIRLEY, JRNL AUTH 2 L.FERON,V.FLEMINGTON,M.A.GRAHAM,R.GREENWOOD,N.GRIFFIN, JRNL AUTH 3 L.HANSON,P.HOPCROFT,T.D.HOWARD,J.HUDSON,M.JAMES,C.D.JONES, JRNL AUTH 4 C.R.JONES,S.LAMONT,R.LEWIS,N.LINDSAY,K.ROBERTS,I.SIMPSON, JRNL AUTH 5 S.ST-GALLAY,S.SWALLOW,J.TANG,M.TONGE,Z.WANG,B.ZHAI JRNL TITL STRUCTURE-GUIDED DISCOVERY OF POTENT AND SELECTIVE JRNL TITL 2 INHIBITORS OF ERK1/2 FROM A MODESTLY ACTIVE AND PROMISCUOUS JRNL TITL 3 CHEMICAL START POINT. JRNL REF J. MED. CHEM. V. 60 3438 2017 JRNL REFN ISSN 1520-4804 JRNL PMID 28376306 JRNL DOI 10.1021/ACS.JMEDCHEM.7B00267 REMARK 2 REMARK 2 RESOLUTION. 2.14 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.6 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.14 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 44.20 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.0 REMARK 3 NUMBER OF REFLECTIONS : 20940 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.248 REMARK 3 R VALUE (WORKING SET) : 0.247 REMARK 3 FREE R VALUE : 0.259 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 6.270 REMARK 3 FREE R VALUE TEST SET COUNT : 1312 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.000 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 11 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.14 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.24 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 95.51 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2684 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.4260 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2520 REMARK 3 BIN R VALUE (WORKING SET) : 0.4290 REMARK 3 BIN FREE R VALUE : 0.3930 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 6.11 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 164 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2659 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 35 REMARK 3 SOLVENT ATOMS : 73 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 46.05 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 50.08 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 6.47770 REMARK 3 B22 (A**2) : -6.96460 REMARK 3 B33 (A**2) : 0.48690 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 1.93250 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.410 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.271 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.197 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.281 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.202 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.927 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.900 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2762 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3766 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 916 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 62 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 398 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2762 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 368 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 3424 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.22 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.19 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 20.18 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): -4.2987 8.5561 47.5282 REMARK 3 T TENSOR REMARK 3 T11: -0.0442 T22: 0.0190 REMARK 3 T33: 0.0051 T12: -0.0206 REMARK 3 T13: 0.0514 T23: 0.0278 REMARK 3 L TENSOR REMARK 3 L11: 1.2751 L22: 1.1326 REMARK 3 L33: 1.2335 L12: 0.5822 REMARK 3 L13: 0.6146 L23: 0.5371 REMARK 3 S TENSOR REMARK 3 S11: -0.1151 S12: 0.1186 S13: 0.1326 REMARK 3 S21: -0.1770 S22: 0.0889 S23: 0.0653 REMARK 3 S31: -0.0832 S32: 0.0400 S33: 0.0261 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5NHF COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 21-MAR-17. REMARK 100 THE DEPOSITION ID IS D_1200004123. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 21-NOV-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID29 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.976 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XIA2 REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20963 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.140 REMARK 200 RESOLUTION RANGE LOW (A) : 46.260 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.2 REMARK 200 DATA REDUNDANCY : 3.200 REMARK 200 R MERGE (I) : 0.08900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.14 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.22 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.4 REMARK 200 DATA REDUNDANCY IN SHELL : 3.10 REMARK 200 R MERGE FOR SHELL (I) : 0.79200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.68 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.22 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 30% PEGMME2K, 100MM HEPES PH 7.6, REMARK 280 200MM AMMONIUM SULFATE, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 35.02350 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 180 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15330 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -12.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -18 REMARK 465 HIS A -17 REMARK 465 HIS A -16 REMARK 465 HIS A -15 REMARK 465 HIS A -14 REMARK 465 HIS A -13 REMARK 465 HIS A -12 REMARK 465 GLY A -11 REMARK 465 GLY A -10 REMARK 465 GLY A -9 REMARK 465 GLU A -8 REMARK 465 ASN A -7 REMARK 465 LEU A -6 REMARK 465 TYR A -5 REMARK 465 PHE A -4 REMARK 465 GLN A -3 REMARK 465 GLY A -2 REMARK 465 SER A -1 REMARK 465 HIS A 0 REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 ALA A 3 REMARK 465 ALA A 4 REMARK 465 ALA A 5 REMARK 465 ALA A 6 REMARK 465 ALA A 7 REMARK 465 GLY A 8 REMARK 465 ALA A 9 REMARK 465 GLY A 10 REMARK 465 PRO A 11 REMARK 465 MET A 333 REMARK 465 GLU A 334 REMARK 465 LEU A 335 REMARK 465 ASP A 336 REMARK 465 PRO A 356 REMARK 465 GLY A 357 REMARK 465 TYR A 358 REMARK 465 ARG A 359 REMARK 465 SER A 360 REMARK 465 LEU A 361 REMARK 465 GLU A 362 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 12 CG CD OE1 OE2 REMARK 470 MET A 13 CG SD CE REMARK 470 ARG A 15 CG CD NE CZ NH1 NH2 REMARK 470 GLN A 17 CG CD OE1 NE2 REMARK 470 ASP A 20 CG OD1 OD2 REMARK 470 ASN A 27 CG OD1 ND2 REMARK 470 GLU A 33 CG CD OE1 OE2 REMARK 470 LEU A 46 CG CD1 CD2 REMARK 470 LYS A 48 CG CD CE NZ REMARK 470 LYS A 55 CG CD CE NZ REMARK 470 GLU A 60 CG CD OE1 OE2 REMARK 470 ARG A 77 CD NE CZ NH1 NH2 REMARK 470 ARG A 79 CD NE CZ NH1 NH2 REMARK 470 LYS A 99 CG CD CE NZ REMARK 470 ASP A 100 CG OD1 OD2 REMARK 470 GLU A 109 CG CD OE1 OE2 REMARK 470 LYS A 114 CE NZ REMARK 470 GLU A 186 CG CD OE1 OE2 REMARK 470 ARG A 225 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 231 CG CD CE NZ REMARK 470 GLU A 250 CG CD OE1 OE2 REMARK 470 LYS A 259 CG CD CE NZ REMARK 470 LYS A 270 CG CD CE NZ REMARK 470 ARG A 277 CG CD NE CZ NH1 NH2 REMARK 470 GLN A 315 CG CD OE1 NE2 REMARK 470 LYS A 330 CG CD CE NZ REMARK 470 PHE A 331 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS A 340 CG CD CE NZ REMARK 470 LYS A 342 CG CD CE NZ REMARK 470 GLU A 349 CG CD OE1 OE2 REMARK 470 ARG A 353 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O MET A 98 NZ LYS A 344 2.18 REMARK 500 OD1 ASP A 179 N TYR A 205 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 OE2 GLU A 96 CD1 LEU A 265 1454 2.05 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE A 31 -52.82 -122.06 REMARK 500 ARG A 148 -4.25 78.63 REMARK 500 ASP A 167 71.66 60.47 REMARK 500 ASN A 201 17.82 -147.13 REMARK 500 LEU A 294 58.41 -92.85 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 8X5 A 402 DBREF 5NHF A 1 360 UNP P28482 MK01_HUMAN 1 360 SEQADV 5NHF MET A -18 UNP P28482 INITIATING METHIONINE SEQADV 5NHF HIS A -17 UNP P28482 EXPRESSION TAG SEQADV 5NHF HIS A -16 UNP P28482 EXPRESSION TAG SEQADV 5NHF HIS A -15 UNP P28482 EXPRESSION TAG SEQADV 5NHF HIS A -14 UNP P28482 EXPRESSION TAG SEQADV 5NHF HIS A -13 UNP P28482 EXPRESSION TAG SEQADV 5NHF HIS A -12 UNP P28482 EXPRESSION TAG SEQADV 5NHF GLY A -11 UNP P28482 EXPRESSION TAG SEQADV 5NHF GLY A -10 UNP P28482 EXPRESSION TAG SEQADV 5NHF GLY A -9 UNP P28482 EXPRESSION TAG SEQADV 5NHF GLU A -8 UNP P28482 EXPRESSION TAG SEQADV 5NHF ASN A -7 UNP P28482 EXPRESSION TAG SEQADV 5NHF LEU A -6 UNP P28482 EXPRESSION TAG SEQADV 5NHF TYR A -5 UNP P28482 EXPRESSION TAG SEQADV 5NHF PHE A -4 UNP P28482 EXPRESSION TAG SEQADV 5NHF GLN A -3 UNP P28482 EXPRESSION TAG SEQADV 5NHF GLY A -2 UNP P28482 EXPRESSION TAG SEQADV 5NHF SER A -1 UNP P28482 EXPRESSION TAG SEQADV 5NHF HIS A 0 UNP P28482 EXPRESSION TAG SEQADV 5NHF LEU A 46 UNP P28482 VAL 46 CONFLICT SEQADV 5NHF LEU A 361 UNP P28482 EXPRESSION TAG SEQADV 5NHF GLU A 362 UNP P28482 EXPRESSION TAG SEQRES 1 A 381 MET HIS HIS HIS HIS HIS HIS GLY GLY GLY GLU ASN LEU SEQRES 2 A 381 TYR PHE GLN GLY SER HIS MET ALA ALA ALA ALA ALA ALA SEQRES 3 A 381 GLY ALA GLY PRO GLU MET VAL ARG GLY GLN VAL PHE ASP SEQRES 4 A 381 VAL GLY PRO ARG TYR THR ASN LEU SER TYR ILE GLY GLU SEQRES 5 A 381 GLY ALA TYR GLY MET VAL CYS SER ALA TYR ASP ASN LEU SEQRES 6 A 381 ASN LYS VAL ARG VAL ALA ILE LYS LYS ILE SER PRO PHE SEQRES 7 A 381 GLU HIS GLN THR TYR CYS GLN ARG THR LEU ARG GLU ILE SEQRES 8 A 381 LYS ILE LEU LEU ARG PHE ARG HIS GLU ASN ILE ILE GLY SEQRES 9 A 381 ILE ASN ASP ILE ILE ARG ALA PRO THR ILE GLU GLN MET SEQRES 10 A 381 LYS ASP VAL TYR ILE VAL GLN ASP LEU MET GLU THR ASP SEQRES 11 A 381 LEU TYR LYS LEU LEU LYS THR GLN HIS LEU SER ASN ASP SEQRES 12 A 381 HIS ILE CYS TYR PHE LEU TYR GLN ILE LEU ARG GLY LEU SEQRES 13 A 381 LYS TYR ILE HIS SER ALA ASN VAL LEU HIS ARG ASP LEU SEQRES 14 A 381 LYS PRO SER ASN LEU LEU LEU ASN THR THR CME ASP LEU SEQRES 15 A 381 LYS ILE CYS ASP PHE GLY LEU ALA ARG VAL ALA ASP PRO SEQRES 16 A 381 ASP HIS ASP HIS THR GLY PHE LEU THR GLU TYR VAL ALA SEQRES 17 A 381 THR ARG TRP TYR ARG ALA PRO GLU ILE MET LEU ASN SER SEQRES 18 A 381 LYS GLY TYR THR LYS SER ILE ASP ILE TRP SER VAL GLY SEQRES 19 A 381 CYS ILE LEU ALA GLU MET LEU SER ASN ARG PRO ILE PHE SEQRES 20 A 381 PRO GLY LYS HIS TYR LEU ASP GLN LEU ASN HIS ILE LEU SEQRES 21 A 381 GLY ILE LEU GLY SER PRO SER GLN GLU ASP LEU ASN CYS SEQRES 22 A 381 ILE ILE ASN LEU LYS ALA ARG ASN TYR LEU LEU SER LEU SEQRES 23 A 381 PRO HIS LYS ASN LYS VAL PRO TRP ASN ARG LEU PHE PRO SEQRES 24 A 381 ASN ALA ASP SER LYS ALA LEU ASP LEU LEU ASP LYS MET SEQRES 25 A 381 LEU THR PHE ASN PRO HIS LYS ARG ILE GLU VAL GLU GLN SEQRES 26 A 381 ALA LEU ALA HIS PRO TYR LEU GLU GLN TYR TYR ASP PRO SEQRES 27 A 381 SER ASP GLU PRO ILE ALA GLU ALA PRO PHE LYS PHE ASP SEQRES 28 A 381 MET GLU LEU ASP ASP LEU PRO LYS GLU LYS LEU LYS GLU SEQRES 29 A 381 LEU ILE PHE GLU GLU THR ALA ARG PHE GLN PRO GLY TYR SEQRES 30 A 381 ARG SER LEU GLU MODRES 5NHF CME A 161 CYS MODIFIED RESIDUE HET CME A 161 10 HET SO4 A 401 5 HET 8X5 A 402 30 HETNAM CME S,S-(2-HYDROXYETHYL)THIOCYSTEINE HETNAM SO4 SULFATE ION HETNAM 8X5 2-[2-(OXAN-4-YLAMINO)PYRIMIDIN-4-YL]-5-(PHENYLMETHYL)- HETNAM 2 8X5 6,7-DIHYDRO-1~{H}-PYRROLO[3,2-C]PYRIDIN-4-ONE FORMUL 1 CME C5 H11 N O3 S2 FORMUL 2 SO4 O4 S 2- FORMUL 3 8X5 C23 H25 N5 O2 FORMUL 4 HOH *73(H2 O) HELIX 1 AA1 HIS A 61 PHE A 78 1 18 HELIX 2 AA2 LEU A 112 GLN A 119 1 8 HELIX 3 AA3 SER A 122 ALA A 143 1 22 HELIX 4 AA4 LYS A 151 SER A 153 5 3 HELIX 5 AA5 ASP A 175 ASP A 179 5 5 HELIX 6 AA6 THR A 190 ARG A 194 5 5 HELIX 7 AA7 ALA A 195 ASN A 201 1 7 HELIX 8 AA8 LYS A 207 ASN A 224 1 18 HELIX 9 AA9 LEU A 234 GLY A 245 1 12 HELIX 10 AB1 SER A 248 CYS A 254 1 7 HELIX 11 AB2 ASN A 257 LEU A 267 1 11 HELIX 12 AB3 PRO A 274 PHE A 279 1 6 HELIX 13 AB4 ASP A 283 LEU A 294 1 12 HELIX 14 AB5 GLU A 303 ALA A 309 1 7 HELIX 15 AB6 HIS A 310 GLU A 314 5 5 HELIX 16 AB7 ASP A 318 GLU A 322 5 5 HELIX 17 AB8 PRO A 339 ALA A 352 1 14 HELIX 18 AB9 ARG A 353 GLN A 355 5 3 SHEET 1 AA1 2 MET A 13 VAL A 14 0 SHEET 2 AA1 2 GLN A 17 VAL A 18 -1 O GLN A 17 N VAL A 14 SHEET 1 AA2 5 TYR A 25 GLU A 33 0 SHEET 2 AA2 5 GLY A 37 ASP A 44 -1 O SER A 41 N SER A 29 SHEET 3 AA2 5 VAL A 49 ILE A 56 -1 O ILE A 53 N CYS A 40 SHEET 4 AA2 5 VAL A 101 ASP A 106 -1 O GLN A 105 N ALA A 52 SHEET 5 AA2 5 ASP A 88 ILE A 90 -1 N ASP A 88 O VAL A 104 SHEET 1 AA3 3 THR A 110 ASP A 111 0 SHEET 2 AA3 3 LEU A 155 LEU A 157 -1 O LEU A 157 N THR A 110 SHEET 3 AA3 3 LEU A 163 ILE A 165 -1 O LYS A 164 N LEU A 156 SHEET 1 AA4 2 VAL A 145 LEU A 146 0 SHEET 2 AA4 2 ARG A 172 VAL A 173 -1 O ARG A 172 N LEU A 146 LINK C THR A 160 N CME A 161 1555 1555 1.32 LINK C CME A 161 N ASP A 162 1555 1555 1.33 CISPEP 1 GLY A 22 PRO A 23 0 4.07 SITE 1 AC1 5 ARG A 191 ARG A 194 TYR A 233 HOH A 518 SITE 2 AC1 5 HOH A 534 SITE 1 AC2 13 ILE A 31 GLY A 34 GLY A 37 VAL A 39 SITE 2 AC2 13 ALA A 52 LYS A 54 ASP A 106 MET A 108 SITE 3 AC2 13 GLU A 109 THR A 110 ASP A 111 LEU A 156 SITE 4 AC2 13 HOH A 542 CRYST1 49.019 70.047 60.363 90.00 109.31 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020400 0.000000 0.007148 0.00000 SCALE2 0.000000 0.014276 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017554 0.00000